Yeah I agree WD.
I'd usually steer clear of putting too much into a binary outcome like this but the Carlyle investment really tips the scales for me.
I've got a pretty decent parcel and will buy more if it dips into the 60s.
Everything says it's a goer but as we all know with bios and clinical trials there's no such thing as a sure thing.
Close enough for me though.
Ann: Opthea to Host Key Opinion Leader Event on April 3, 2024, page-15
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
49.0¢ |
Change
-0.030(5.77%) |
Mkt cap ! $324.7M | |||
| Open | High | Low | Value | Volume |
| 50.5¢ | 50.5¢ | 48.5¢ | $120.1K | 241.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 19749 | 48.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 49.0¢ | 9792 | 7 |
View Market Depth
| Last trade - 12.31pm 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
49.5¢ |
Change
-0.030 ( 4.81 %) |
||||
| Open | High | Low | Volume | ||
| 49.0¢ | 50.0¢ | 48.5¢ | 30092 | ||
| Last updated 12.40pm 06/06/2024 ? | |||||
| OPT (ASX) Chart |